Treatment discontinuation is a major challenge in routine clinical settings. Despite poor
adherence to antipsychotic medication, long acting injectable (LAI) formulations are an …

Background Recent guidelines suggested a wider use of long-acting injectable
antipsychotics (LAI) than previously, but naturalistic data on the consequences of LAI use in …

Aim The aim of this review was to analyze the discontinuation rates during long‐term
treatment with second‐generation antipsychotic long‐acting injection (SGA‐LAI) in adults …

Objective To assess expert consensus on barriers and facilitators for long-acting injectable
antipsychotic (LAI) use and provide clinical recommendations on issues where clinical …

Introduction Long-acting injectable antipsychotics (LAIs) are an effective, but potentially
underutilized treatment option in schizophrenia and other severe mental illnesses …

Objective We aimed to assess whether long-acting injectable antipsychotics (LAIs), which
are initiated in a loading strategy or overlapping with oral antipsychotics (OAPs) and which …

Abstract Background and Objective Long-acting injectable antipsychotics (LAIs) are
associated with better treatment adherence and persistence than oral antipsychotics (OAPs) …

This mirror-image study aimed to evaluate the real-life effectiveness of long-acting injectable
antipsychotics (LAI) in schizophrenia. Patients with schizophrenia initiating LAIs January …

Objective: The objective of this study was to analyze the real-world prevalence of long-acting
injectable (LAI) antipsychotic use and determine when LAIs are being used in sequencing of …

Recently, many authors highlighted the potential advantages of a broader prescription of
long-acting injectable antipsychotics (LAIs) based on various assumptions, including …